Ingalls & Snyder LLC Pfizer Inc Transaction History

Ingalls & Snyder LLC

$2.82 Billion
Q2 2025

A detailed history of Ingalls & Snyder LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ingalls & Snyder LLC holds 755,313 shares of PFE stock, worth $18.6 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

755,313

Previous 58,400 1193.34%

Holding current value

$18.6 Million

Previous $1.48 Million 1137.09%

% of portfolio

0.65%

Previous 0.05%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	BUY	$21.59 - $24.84 $2.38 Million - $2.74 Million	110,393 Added 17.12%	755,313 $18.3 Million
Q1 2025 May 12, 2025	BUY	$25.01 - $27.13 $70,403 - $76,370	2,815 Added 0.44%	644,920 $16.3 Million
Q4 2024 Jan 29, 2025	BUY	$24.8 - $30.19 $512,516 - $623,906	20,666 Added 3.33%	642,105 $17 Million
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $10,941 - $12,399	-395 Reduced 0.06%	621,439 $18 Million
Q2 2024 Jul 31, 2024	SELL	$25.26 - $29.6 $27,735 - $32,500	-1,098 Reduced 0.18%	621,834 $17.4 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $1.19 Million - $1.37 Million	46,130 Added 8.0%	622,932 $17.3 Million
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $678,099 - $880,776	-25,951 Reduced 4.31%	576,802 $16.6 Million
Q3 2023 Nov 02, 2023	BUY	$32.09 - $37.51 $131,665 - $153,903	4,103 Added 0.69%	602,753 $20 Million
Q2 2023 Jul 27, 2023	BUY	$36.12 - $41.79 $25,934 - $30,005	718 Added 0.12%	598,650 $22 Million
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $659,270 - $858,273	16,737 Added 2.88%	597,932 $24.4 Million
Q4 2022 Jan 31, 2023	SELL	$41.75 - $54.5 $2,463 - $3,215	-59 Reduced 0.01%	581,195 $29.8 Million
Q3 2022 Oct 21, 2022	SELL	$43.76 - $53.42 $54,393 - $66,401	-1,243 Reduced 0.21%	581,254 $25.4 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $95,200 - $112,877	-2,046 Reduced 0.35%	582,497 $30.5 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $220,881 - $273,699	4,828 Added 0.83%	584,543 $30.3 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $114,291 - $169,417	2,766 Added 0.48%	579,715 $34.2 Million
Q3 2021 Oct 27, 2021	SELL	$39.25 - $50.42 $763,412 - $980,669	-19,450 Reduced 3.26%	576,949 $24.8 Million
Q2 2021 Aug 03, 2021	SELL	$35.91 - $40.68 $200,593 - $227,238	-5,586 Reduced 0.93%	596,399 $23.4 Million
Q1 2021 Apr 21, 2021	SELL	$33.49 - $37.77 $246,854 - $278,402	-7,371 Reduced 1.21%	601,985 $21.8 Million
Q4 2020 Jan 27, 2021	SELL	$33.47 - $42.56 $302,736 - $384,955	-9,045 Reduced 1.46%	609,356 $22.4 Million
Q3 2020 Oct 21, 2020	BUY	$31.75 - $37.25 $323,500 - $379,540	10,189 Added 1.68%	618,401 $22.7 Million
Q2 2020 Jul 31, 2020	SELL	$30.12 - $36.54 $153,099 - $185,732	-5,083 Reduced 0.83%	608,212 $19.9 Million
Q1 2020 Apr 22, 2020	SELL	$27.03 - $38.62 $62,898 - $89,868	-2,327 Reduced 0.38%	613,295 $20 Million
Q4 2019 Jan 15, 2020	BUY	$32.92 - $37.36 $169,603 - $192,478	5,152 Added 0.84%	615,622 $24.1 Million
Q3 2019 Oct 16, 2019	SELL	$32.49 - $42.13 $290,850 - $377,147	-8,952 Reduced 1.45%	610,470 $21.9 Million
Q2 2019 Jul 11, 2019	BUY	$36.98 - $41.52 $40,567 - $45,547	1,097 Added 0.18%	619,422 $26.8 Million
Q1 2019 Apr 11, 2019	SELL	$37.5 - $41.2 $178,425 - $196,029	-4,758 Reduced 0.76%	618,325 $26.3 Million
Q4 2018 Jan 24, 2019	SELL	$38.47 - $43.86 $470,988 - $536,977	-12,243 Reduced 1.93%	623,083 $27.2 Million
Q3 2018 Oct 24, 2018	BUY	$34.47 - $41.81 $59,736 - $72,456	1,733 Added 0.27%	635,326 $28 Million
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $175,585 - $187,191	5,324 Added 0.85%	633,593 $23 Million
Q1 2018 Apr 17, 2018	BUY	$31.91 - $37.02 $109,610 - $127,163	3,435 Added 0.55%	628,269 $22.3 Million
Q4 2017 Jan 19, 2018	BUY	$33.26 - $35.29 $64,291 - $68,215	1,933 Added 0.31%	624,834 $22.6 Million
Q3 2017 Oct 20, 2017	BUY	$31.0 - $34.15 $19.3 Million - $21.3 Million	622,901	622,901 $22.2 Million

Others Institutions Holding PFE

# of Institutions

3,310

Shares Held

3.63B

Call Options Held

103M

Put Options Held

128M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Account

Ingalls & Snyder LLC Pfizer Inc Transaction History